Related references
Note: Only part of the references are listed.Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
K Dunleavy et al.
Infectious Agents and Cancer (2012)
Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy
Chun Chao et al.
AIDS (2010)
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma
Joseph A. Sparano et al.
BLOOD (2010)
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma
Kieron Dunleavy et al.
BLOOD (2010)
Rituximab in Indolent Lymphomas
Tarek Sousou et al.
SEMINARS IN HEMATOLOGY (2010)
Rituximab in High-Grade Lymphoma
Carsten Zwick et al.
SEMINARS IN HEMATOLOGY (2010)
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study
Julia Bohlius et al.
ANTIVIRAL THERAPY (2009)
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals
Jessica L. Long et al.
AIDS (2008)
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma:: results of a phase II trial
Josep-Maria Ribera et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma
Francois Boue et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
Thomas M. Habermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Prognostic factors in HIV-related diffuse large-cell lymphoma: Before versus after highly active antiretroviral therapy
ST Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
LD Kaplan et al.
BLOOD (2005)
A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy
M Bower et al.
ANNALS OF INTERNAL MEDICINE (2005)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV associated non-Hodgkin's lymphoma: An eastern cooperative oncology group trial (E1494)
JA Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology
RF Little et al.
BLOOD (2003)
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy
WH Wilson et al.
BLOOD (2002)
Share Paper
